ZA745305B - Improvements relating to pyrimidines - Google Patents

Improvements relating to pyrimidines

Info

Publication number
ZA745305B
ZA745305B ZA00745305A ZA745305A ZA745305B ZA 745305 B ZA745305 B ZA 745305B ZA 00745305 A ZA00745305 A ZA 00745305A ZA 745305 A ZA745305 A ZA 745305A ZA 745305 B ZA745305 B ZA 745305B
Authority
ZA
South Africa
Prior art keywords
pyrimidines
improvements relating
relating
Prior art date
Application number
ZA00745305A
Inventor
E Muller
W Haarmann
B Narr
J Roch
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of ZA745305B publication Critical patent/ZA745305B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A63—SPORTS; GAMES; AMUSEMENTS
    • A63C—SKATES; SKIS; ROLLER SKATES; DESIGN OR LAYOUT OF COURTS, RINKS OR THE LIKE
    • A63C19/00—Design or layout of playing courts, rinks, bowling greens or areas for water-skiing; Covers therefor
    • A63C19/02—Shaping of the surface of courts according to the necessities of the different games

Landscapes

  • Engineering & Computer Science (AREA)
  • Architecture (AREA)
  • Civil Engineering (AREA)
  • Structural Engineering (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA00745305A 1973-08-20 1974-08-19 Improvements relating to pyrimidines ZA745305B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732341925 DE2341925A1 (en) 1973-08-20 1973-08-20 2,4, (opt.5-), 6-substd. pyriminidines as antithrombic agents - e.g. 6-methyl-5-nitro-2-piperazino-4-thiomorpolino-pyrimidine

Publications (1)

Publication Number Publication Date
ZA745305B true ZA745305B (en) 1976-04-28

Family

ID=5890167

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00745305A ZA745305B (en) 1973-08-20 1974-08-19 Improvements relating to pyrimidines

Country Status (4)

Country Link
JP (1) JPS5049288A (en)
BE (1) BE818990A (en)
DE (1) DE2341925A1 (en)
ZA (1) ZA745305B (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1172255A (en) * 1980-12-11 1984-08-07 Robert R. Covington Buspirone process
JPH0635450B2 (en) * 1984-03-16 1994-05-11 三井東圧化学株式会社 Thiocyanopyrimidine derivative, its production method and agricultural / horticultural fungicide
US5098902A (en) * 1991-03-18 1992-03-24 Warner-Lambert Company Method of treating neurodegenerative diseases
US5075305A (en) * 1991-03-18 1991-12-24 Warner-Lambert Company Compound, composition and use
US5658923A (en) * 1992-09-18 1997-08-19 Asahi Kasei Kogyo Kabushiki Kaisha Azepine derivatives and use thereof
WO1994006773A1 (en) * 1992-09-18 1994-03-31 Asahi Kasei Kogyo Kabushiki Kaisha Azepine derivative, production thereof, and use thereof
CA2208900C (en) * 1996-07-18 2006-08-01 Lonza Ag Process for preparing 2-pyrimidinecarboxylates
NZ506417A (en) 1998-02-17 2003-05-30 Tularik Inc Anti-viral pyrimidine derivatives
US6410726B1 (en) 2000-01-12 2002-06-25 Tularik Inc. Arylsulfonic acid salts of pyrimidine-based antiviral
KR101052482B1 (en) * 2002-11-21 2011-07-28 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 2,4,6-trisubstituted pyrimidine, a phosphatidylinositol (PI) 3-kinase inhibitor, and their use in the treatment of cancer
EP1927594A1 (en) * 2003-01-14 2008-06-04 Arena Pharmaceuticals, Inc. 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
PL377847A1 (en) * 2003-01-14 2006-02-20 Arena Pharmaceuticals Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
CA2531061A1 (en) * 2003-07-02 2005-01-13 Vertex Pharmaceuticals Incorporated Pyrimidines useful as modulators of voltage-gated ion channels
AR045047A1 (en) 2003-07-11 2005-10-12 Arena Pharm Inc ARILO AND HETEROARILO DERIVATIVES TRISUSTITUIDOS AS MODULATORS OF METABOLISM AND PROFILAXIS AND TREATMENT OF DISORDERS RELATED TO THEMSELVES
ATE532772T1 (en) 2003-07-30 2011-11-15 Xenon Pharmaceuticals Inc PIPERAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS
ES2568769T3 (en) 2003-07-30 2016-05-04 Xenon Pharmaceuticals Inc. Piperazine derivatives and their use as therapeutic agents
HUP0400405A3 (en) * 2004-02-10 2009-03-30 Sanofi Synthelabo Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
JP2007217282A (en) * 2004-03-04 2007-08-30 Astellas Pharma Inc Substituted pyrimidine derivative
AU2005286793A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes
US7777036B2 (en) 2004-09-20 2010-08-17 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
AU2005286728A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
AU2005286731A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
MX2007003325A (en) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors.
CA2580856A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP1804799B1 (en) 2004-09-20 2013-08-21 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
DOP2006000010A (en) 2005-01-10 2006-07-31 Arena Pharm Inc PROCEDURE TO PREPARE AROMATIC ETERES
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
EP1904491A2 (en) 2005-05-31 2008-04-02 Vertex Pharmaceuticals Incorporated Heterocycles useful as modulators of ion channels
EP2029138A1 (en) 2005-06-03 2009-03-04 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
GB0512844D0 (en) * 2005-06-23 2005-08-03 Novartis Ag Organic compounds
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي PI-3 Kinase inhibitors and methods of their use
EP2118087B1 (en) 2007-02-06 2012-03-28 Novartis AG Pi 3-kinase inhibitors and methods of their use
CN101801954B (en) 2007-09-20 2013-10-09 Irm责任有限公司 Compounds and compositions as modulators of GPR119 activity
US8563715B2 (en) 2008-03-31 2013-10-22 Zenyaku Kogyo Kabushikikaisha Pyrimidine derivative having cell protecting effect and uses thereof
AU2009333559B2 (en) * 2008-12-09 2015-03-12 Gilead Sciences, Inc. Modulators of toll-like receptors
BR112013008100A2 (en) 2010-09-22 2016-08-09 Arena Pharm Inc "gpr19 receptor modulators and the treatment of disorders related thereto."
MX342326B (en) 2011-09-27 2016-09-26 Novartis Ag 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh.
CN103204816B (en) 2012-01-16 2016-04-27 中国人民解放军军事医学科学院毒物药物研究所 Piperazinylpyrimidine analog derivative and its production and use
UY34632A (en) 2012-02-24 2013-05-31 Novartis Ag OXAZOLIDIN- 2- ONA COMPOUNDS AND USES OF THE SAME
US9296733B2 (en) 2012-11-12 2016-03-29 Novartis Ag Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
ES2665619T3 (en) 2013-03-14 2018-04-26 Novartis Ag 3-Pyrimidin-4-yl-oxazolidin-2-ones as mutant HDI inhibitors
AU2016205361C1 (en) 2015-01-06 2021-04-08 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
SI3310760T1 (en) 2015-06-22 2023-02-28 Arena Pharmaceuticals, Inc. Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta(b)indol-3-yl)acetic acid for use in s1p1 receptor-associated disorders
KR20190116416A (en) 2017-02-16 2019-10-14 아레나 파마슈티칼스, 인크. Compounds and Methods for Treating Primary Bile Cholangitis

Also Published As

Publication number Publication date
JPS5049288A (en) 1975-05-01
DE2341925A1 (en) 1975-03-06
BE818990A (en) 1975-02-19

Similar Documents

Publication Publication Date Title
ZA745305B (en) Improvements relating to pyrimidines
ZA742415B (en) Improvements relating to knef arthroplasty
ZA743933B (en) Improvements relating to fasteners
ZA742939B (en) Improvements in or relating to burners
ZA74145B (en) Improvements relating to burners
HK32180A (en) Improvements relating to electrothernal printers
ZA742816B (en) Improvements relating to substituted butyrophenones
IL44884A0 (en) Improvements relating to buildings
ZA74116B (en) Improvements relating to housings
ZA744314B (en) Improvements in or relating to cephalosporin compounds
ZA74773B (en) Improvements in or relating to wiretinning systems
ZA741173B (en) Improvements relating to substituted 2-phenylamino-imidazolines-(2)
ZA742137B (en) Improvements relating to ventilators
ZA741309B (en) Improvements in or relating to packagung
AU7259074A (en) Pyrimidine derivatives
ZA744512B (en) Novel benzyl pyrimidines
ZA741301B (en) Improvements relating to 1-aryloxy-2-hydroxy-3-alkinylaminopropanes
ZA745267B (en) Improvements relating to 1-(m-acyloxyphenyl)-hydroxy-2-n-alkylamino-ethanes
HK58377A (en) Improvements in or relating to cine-film cameras
ZA741459B (en) Improvements relating to ventilators
ZA746470B (en) Substituted uracils
ZA738006B (en) Improvements in or relating to woolgrease
JPS5149961A (en) tateamiki no shujiku to garaseigyosochi no dokihoho
ZA744904B (en) Improvements in or relating to cephalosporin compounds
HK17977A (en) Improvements in or relating to cameras